KEAP1 is frequently mutated in lung cancer, and KEAP1-mutant lung cancer exhibits NRF2 hyperactivation and aberrant expression of SLC7A11 (Cancer Genome Atlas Research, 2012, 2014). This evidence concerns the gene SLC7A11 and lung carcinoma.